{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:51:32Z","timestamp":1789840292492,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Serratia marcescens, as a Gram-negative opportunistic pathogen, is a rare cause of peritonitis and has worse clinical outcomes than Gram-positive peritonitis. In this case report, we describe a case of Serratia marcescens associated peritonitis that was successfully cured without catheter removal. A 40-year-old male patient with peritoneal dialysis who worked in the catering industry was admitted to the hospital for 16 hours after the discovery of cloudy peritoneal dialysate and abdominal pain. Ceftazidime and cefazolin sodium were immediately given intravenously as an empirical antibiotic regimen. After detecting Serratia marcescens in the peritoneal diasate culture, the treatment was switched to ceftazidime and levofloxacin. The routine examination of peritoneal dialysate showed a significant decrease in white blood cells, the peritoneal dialysate became clear, and the peritoneal dialysis catheter was retained. The patient was treated for 2 weeks and treated with oral antibiotics for 1 week. It is necessary to further strengthen the hygiene of work environment to prevent Serratia marcescens infection in peritoneal dialysis patients. We recommend that patients with Serratia marcescens associated peritonitis should be treated with a combination of antibiotics as early as possible empirically, and at the same time, the peritoneal dialysis fluid culture should be improved, and the antibiotic regimen should be timely adjusted according to the drug sensitivity results. For patients with clinical symptoms for more than 3 days, considering the strong virulence of Serratia marcescens, whether to use meropenem directly or not can provide a reference for clinical decision-making. Further clinical studies are needed to achieve more precise anti-infective treatment.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1373036","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:58:37Z","timestamp":1717063117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A rare case of successful treatment of peritoneal dialysis patient with Serratia marcescens peritonitis without catheter removal: case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Ruizhi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ajkd.2009.08.020","article-title":"Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes","volume":"55","author":"Barraclough","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1017\/ice.2022.187","article-title":"Serratia marcescens outbreak in a neonatal intensive care unit associated with contaminated donor milk","volume":"44","author":"Bechmann","year":"2023","journal-title":"Infect. Control Hosp Epidemiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2020.06.007","article-title":"Is peritoneal dialysis superior to hemodialysis as far as cardiovascular risk? Another unsolved dilemma for maintenance dialysis","volume":"307","author":"Bellasi","year":"2020","journal-title":"Atherosclerosis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nmni.2016.01.012","article-title":"Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysis","volume":"10","author":"Bhave","year":"2016","journal-title":"New Microbes New Infect."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155489","article-title":"Proteomic research in peritoneal dialysis","volume":"21","author":"Bonomini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/aem.00105-23","article-title":"Serratia marcescens colonization in a neonatal intensive care unit has multiple sources, with sink drains as a major reservoir","volume":"89","author":"Bourdin","year":"2023","journal-title":"Appl. Environ. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.23736\/S2724-5276.17.04856-3","article-title":"Epidemiology of Serratia marcescens infections in NICU of a Teaching and Research Hospital in Northern Italy","volume":"75","author":"Buttinelli","year":"2023","journal-title":"Minerva Pediatr. (Torino)."},{"key":"B8","first-page":"S674","article-title":"The outbreak of Serratia marcescens bacteremia in a pediatric ward, Siriraj Hospital 1997","author":"Chokephaibulkit","year":"2002","journal-title":"J. Med. Assoc. Thai."},{"key":"B9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archinte.1968.03640020033006","article-title":"Serratia marcescens septicemia","volume":"121","author":"Dodson","year":"1968","journal-title":"Arch. Intern. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","article-title":"A narrative review of chronic kidney disease in clinical practice: Current Challenges and Future Perspectives","volume":"39","author":"Evans","year":"2022","journal-title":"Adv. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhin.2005.09.015","article-title":"What is the best screening method to detect Serratia marcescens colonization during an outbreak in a neonatal intensive care nursery","volume":"62","author":"Giles","year":"2006","journal-title":"J. Hosp Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/089686089701700416","article-title":"Limited systemic absorption of intraperitoneal ceftizoxime in a patient with Serratia marcescens peritonitis","volume":"17","author":"Grabe","year":"1997","journal-title":"Perit Dial Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s42770-021-00465-8","article-title":"Repurposing of antidiabetics as Serratia marcescens virulence inhibitors","volume":"52","author":"Hegazy","year":"2021","journal-title":"Braz. J. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - A systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1128\/CMR.00036-08","article-title":"Multiresistant Serratia marcescens peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) successfully treated with Azthreonam (S26,776) a new monobactam antibiotic","volume":"21","author":"Hortling","year":"1984","journal-title":"Clin. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3947\/ic.2013.45.1.105","article-title":"Serratia marcescens peritonitis in a diabetic patient receiving continuous ambulatory peritoneal dialysis","volume":"45","author":"Kang","year":"2013","journal-title":"Infect. Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.ajkd.2023.03.011","article-title":"Updates on infectious and other complications in peritoneal dialysis: Core curriculum 2023","volume":"82","author":"Khan","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/jac\/dky084","article-title":"Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC \u03b2-lactamase","volume":"73","author":"Kohlmann","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18763","DOI":"10.1038\/s41598-020-75918-5","article-title":"Relationship between initial peritoneal dialysis modality and risk of peritonitis","volume":"10","author":"Kokubu","year":"2020","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00786-21","article-title":"A genome-scale antibiotic screen in serratia marcescens identifies ydgH as a conserved modifier of cephalosporin and detergent susceptibility","volume":"65","author":"Lazarus","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3747\/pdi.2010.00049","article-title":"Peritoneal dialysis-related infections recommendations: 2010 update","volume":"30","author":"Li","year":"2010","journal-title":"Perit Dial Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ajic.2011.08.019","article-title":"Consecutive Serratia marcescens multiclone outbreaks in a neonatal intensive care unit","volume":"40","author":"Maltezou","year":"2012","journal-title":"Am. J. Infect. Control."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1086\/502466","article-title":"Molecular epidemiology of Serratia marcescens outbreaks in two neonatal intensive care units","volume":"25","author":"Milisavljevic","year":"2004","journal-title":"Infect. Control Hosp Epidemiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ekir.2016.05.003","article-title":"The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis patients: The PROMPT study","volume":"1","author":"Muthucumarana","year":"2016","journal-title":"Kidney Int. Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6547","DOI":"10.1038\/s41598-021-86071-y","article-title":"Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis","volume":"11","author":"Oki","year":"2021","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s40620-023-01759-w","article-title":"Peritoneal dialysis discontinuation: to the root of the problem","volume":"36","author":"Piarulli","year":"2023","journal-title":"J. Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/cid\/ciy576","article-title":"Ceftazidime\/avibactam, meropenem\/vaborbactam, or both? Clinical and formulary considerations","volume":"68","author":"Pogue","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1128\/AAC.50.3.962-967.2006","article-title":"Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii","volume":"50","author":"Power","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12941-017-0192-2","article-title":"Killing of Serratia marcescens biofilms with chloramphenicol","volume":"16","author":"Ray","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B34","doi-asserted-by":"publisher","first-page":"Svii, S1","DOI":"10.1053\/j.ajkd.2015.05.001","article-title":"US renal data system 2014 annual data report: Epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.nefro.2016.11.009","article-title":"Serratia marcescens, Morganella morganii, Klebsiella oxytoca related peritonitis attacks in a patient on automated peritoneal dialysis: A case report","volume":"37","author":"Sarihan","year":"2017","journal-title":"Nefrologia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1469-0691.2005.01222.x","article-title":"Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia","volume":"11","author":"Szeto","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2215\/CJN.14631218","article-title":"Peritoneal dialysis-associated peritonitis","volume":"14","author":"Szeto","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A primer on ampC \u03b2-lactamases: Necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3747\/pdi.2009.00052","article-title":"Intraperitoneal meropenem administration: a possible alternative to the intravenous route","volume":"30","author":"Van Ende","year":"2010","journal-title":"Perit Dial Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1574-6976.2007.00071.x","article-title":"Quorum sensing in serratia","volume":"31","author":"Van Houdt","year":"2007","journal-title":"FEMS Microbiol. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3747\/pdi.2012.00155","article-title":"Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis","volume":"33","author":"Vlaar","year":"2013","journal-title":"Perit Dial Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/archinte.1951.03810100045004","article-title":"Infection due to chromobacteria; report of 11 cases","volume":"88","author":"Wheat","year":"1951","journal-title":"AMA Arch. Intern. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.ajkd.2017.08.028","article-title":"Comparison of patient survival between hemodialysis and peritoneal dialysis among patients eligible for both modalities","volume":"71","author":"Wong","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ccr3.3649","article-title":"Successful treatment of Serratia Marcescens peritonitis in a patient receiving peritoneal dialysis","volume":"9","author":"Yang","year":"2021","journal-title":"Clin. Case Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/antibiotics12020367","article-title":"Antimicrobial treatment of serratia marcescens invasive infections: systematic review","volume":"12","author":"Zivkovic Zaric","year":"2023","journal-title":"Antibiotics (Basel)"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1373036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:58:41Z","timestamp":1717063121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1373036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2024.1373036"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1373036","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"article-number":"1373036"}}